It is essential to discuss all potential risks and concerns with your surgeon during your consultation to ensure you are fully informed before proceeding with the procedure
Consistent with this expectation, Argyrakopoulou et al reported that in a cohort of obese individuals treated with liraglutide, the dominant change was a reduction in fat mass, accompanied by only a minimal decline in lean mass
Because NAION often results in permanent impairment, damages in GLP-1 vision loss lawsuits may include: Medical expenses and ongoing care Loss of income or earning capacity Loss of independence and daily functioning Pain, suffering, and emotional distress Given the complexity of pharmaceutical litigation and the scientific issues involved, it is critical to speak with a law firm experienced in handling national MDLs and serious injury claims
ISBN 978-1-4020-0178-9 via Google Books
By 4 months, 18.7% retained benefits compared to 0% in placebo recipients
Protein Cell 7 , 325337 (2016) Cherezov, V